Genetic variations in the 5-lipoxygenase core promoter: Description and functional implications

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 2 II, 2000, Pages

  Silverman, Eric S ^a   Drazen, Jeffrey M ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE;

GENE ACTIVATION; GENE ACTIVITY; GENE CONTROL; GENE INDUCTION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC VARIABILITY; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; RNA TRANSLATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 0034053934     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.supplement_1.ltta-16     Document Type: Review

References (17)

1. Hoshiko, S., O. Rådmark, and B. Samuelsson. 1990. Characterization of the human 5-lipoxygenase gene promoter. Proc. Natl. Acad. Sci. U.S.A. 87:9073-9077.
2. Stankova, J., M. Rolapleszezynski, and C. M. Dubois. 1995. Granulocyte-macrophage colony-stimulating factor increases 5-lipoxygenase gene transcription and protein expression in human neutrophils. Blood 85:3719-3726.
3. Steinhilber, D., S. Hoshiko, J. Grunewald, O. Rådmark, and B. Samuelsson. 1993. Serum factors regulate 5-lipoxygenase activity in maturating HL60 cells. Biochim. Biophys. Acta 1178:1-8.
4. Ponton, A., J. P. Thirion, and P. Sirois. 1997. Repression of the 5-lipoxygenase gene by c-myb overexpression in differentiated HL-60 cells. Prostaglandins 53:49-58.
5. Pouliot, M., P. P. McDonald, L. Khamzina, P. Borgeat, and S. R. McColl. 1994. Granulocyte-macrophage colony-stimulating factor enhances 5-lipoxygenase levels in human polymorphonuclear leukocytes. J. Immunol. 152:851-858.
6. Peters-Golden, M., and R. W. McNish. 1993. Redistribution of 5-lipoxygenase and cytosolic phospholipase A2 to the nuclear fraction upon macrophage activation. Biochem. Biophys. Res. Commun. 196:147-153.
7. Lepley, R. A., D. T. Muskardin, and F. A. Fitzpatrick. 1996. Tyrosine kinase activity modulates catalysis and translocation of cellular 5-lipoxygenase. J. Biol. Chem. 271:6179-6184.
8. Bergstrom, S. 1967. Prostaglandins: members of a hormonal system. Science 157:382-391.
9. Lepley, R. A., and F. A. Fitzpatrick. 1994. Irreversible inactivation of 5-lipoxygenase by leukotriene A4: characterization of product inactivation with purified enzyme and intact leukocytes. J. Biol. Chem. 269: 2627-2631.
10. Jakobsson, P. J., D. Steinhilber, B. Odlander, O. Rådmark, H. E. Claesson, and B. Samuelsson. 1992. On the expression and regulation of 5-lipoxygenase in human lymphocytes. Proc. Natl Acad. Sci. U.S.A. 89: 3521-3525.
11. Piechele, G., S. Colli, E. Tremoli, and A. Maggi. 1993, 5-Lipoxygenase gene expression in HL60 cells during differentiation with DMSO. Pharmacol. Res. 27:53-60.
12. Steinhilber, D., O. Rådmark, and B. Samuelsson. 1993. Transforming growth factor-beta upregulates 5-lipoxygenase activity during myeloid cell maturation. Proc. Natl. Acad. Sci. U.S.A. 90:5984-5988.
13. Courey, A. J., and R. Tjian. 1992. Mechanisms of transcriptional control as revealed by studies of human transcription factor Sp1. In S. L. McKnight and K. R. Yamamoto, editors. Transcriptional Regulation. Cold Spring Harbor Press, Cold Spring Harbor, NY. 743-769.
14. Khachigian, L. M., V. Linder, A. J. Williams, and T. Collins. 1996. Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science 271:1427-1431.
15. Silverman, E. S., L. M. Khachigian, V. Lindner, A. J. Williams, and T. Collins. 1997. Inducible PDGF-A chain transcription in smooth muscle cells is mediated by Egr-1 displacement of Sp1 and Sp3. Am. J. Physiol. 273:H1415-H1426
16. In, K. H., K. Asano, D. Beier, J. Grobbolz, P. W. Finn, E. K. Silverman, E. S. Silverman, T. Collins, A. R. Fischer, T. P. Keith, K. Serino, S. W. Kim, G. T. Desanctis, C. Yandava, A. Pillari, P. Rubin, J. Kemp. E. Israel, W. Busse, D. Ledford, J. J. Murray, A. Segal, D. Tinkleman, and J. M. Drazen. 1997. Naturally occurring mutations in the human 5-lipoxygenasc gene promoter that modify transcription factor binding and reporter gene transcription. J. Clin. Invest. 99:1130-1137.
17. Israel, E., P. Rubin, J. P. Kemp, J. Grossman, W. E. Pierson, S. C. Siegel, D. Tinkelman, J. J. Murray, W. Busse, A. T. Segal, J. Fish, H. B. Kaiser, D. Ledford, S. Wenzel, R. Rosenthal, J. Cohn, C. Lanni, H. Pearlman, P. Karahalios, and J. M. Drazen. 1993. The effect of inhibition of 5-lipoxygenase by zileuton in mild to moderate asthma. Ann. Intern. Med. 119:1059-1066.